Global Research in Paediatrics
Home > News
2013-07-08
events
5th "Meet the Expert in Paediatric Formulations" webinar - 3rd October 2013
Presented by Hannah Batchelor

 

GRiP is pleased to announce the 5th webinar of the "Meet the Experts in Paediatric Formulations" series, organised by the GRiP WP5 team.

 

The webinar is titled “In-vitro biopharmaceutic methods in the development of oral dosage forms for children” and will take place on Thursday 3rd October 2013 at 3:00 pm GMT. 

 

It will be presented by Hannah Batchelor. Hannah graduated from University of Sheffield in 1996 and worked as a formulation scientist at Reckitt and Colman.  In 2000 she was awarded her PhD in Drug Delivery from the University of London taking up a lectureship in Pharmaceutics at Aston University focusing on targeted drug delivery systems & gastro-retentive therapies. In 2008 she joined AstraZeneca & led the paediatric biopharmaceutics research group.  In 2011 she joined the R&D team at Heart of England NHS Foundation Trust to facilitate NHS led research & develop collaborations with regional Universities. Hannah is currently a Formulations Research Fellow funded by the Medicines for Children Network & based at the University of Birmingham.  She works on the design & manipulation of medicines to create age appropriate drug formulations to maximise clinical efficacy in paediatric patients. Her research interests lie in the optimisation of drug formulations to maximise their biopharmaceutical performance.

 

If you would like to take part in the next webinar please contact Barbara Richards at grip@mcrn.org.uk to register or if you have any questions.  We hope you are able to join us, and look forward to your questions and comments during this interactive webinar.

 

PLEASE NOTE: the host will be available to answer any questions about the webinar topic for one month after the webinar. Questions can be submitted via the GRiP Blog

 

Please dowload the webinar announcement by clicking here.

 

For more information about GRiP Webinars, please read here.